Astromech acquires Form Bio in $230 million all-stock deal
Astromech’s $230 million all-stock acquisition of Form Bio joins evolutionary modeling with gene therapy design, gives Andrew Busey a technology role, and adds tools used by Eli Lilly.
Topic
Topic
Astromech’s $230 million all-stock acquisition of Form Bio joins evolutionary modeling with gene therapy design, gives Andrew Busey a technology role, and adds tools used by Eli Lilly.